Picard Medical, Inc. (PMI)
NYSEAMERICAN: PMI · Real-Time Price · USD
3.640
+0.210 (6.12%)
Aug 10, 2026, 4:00 PM EDT - Market closed
Picard Medical Revenue
Picard Medical had revenue of $1.15M in the quarter ending March 31, 2026, with 85.48% growth. This brings the company's revenue in the last twelve months to $5.47M, up 80.47% year-over-year. In the year 2025, Picard Medical had annual revenue of $4.94M with 12.50% growth.
Revenue (ttm)
$5.47M
Revenue Growth
+80.47%
P/S Ratio
1.37
Revenue / Employee
$72,933
Employees
75
Market Cap
7.48M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.94M | 549.00K | 12.50% |
| Dec 31, 2024 | 4.39M | -652.00K | -12.93% |
| Dec 31, 2023 | 5.04M | 930.00K | 22.61% |
| Dec 31, 2022 | 4.11M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
PMI News
- 10 days ago - Picard Medical / SynCardia Presents Emperor Total Artificial Heart Architecture for the First Time at IEEE EMBC 2026 - GlobeNewsWire
- 14 days ago - Picard Medical / SynCardia to Present Next-Generation Emperor Total Artificial Heart Technology at IEEE EMBC 2026 - GlobeNewsWire
- 14 days ago - Picard Medical announces NYSE acceptance of plan to regain compliance - TheFly
- 14 days ago - Picard Medical Receives NYSE American Acceptance of Compliance Plan - GlobeNewsWire
- 20 days ago - Picard Medical announces 1-for-50 reverse stock split - TheFly
- 20 days ago - Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance - GlobeNewsWire
- 25 days ago - Picard Medical Proxy statement: Proxy filing - Filings
- 26 days ago - Artificial Organs Publishes Independent Commentary on Picard Medical and SynCardia's Emperor Total Artificial Heart Program - GlobeNewsWire